Department of Rheumatology and Clinical Immunology
TheDFG-funded Research Training Group (RTG) 3095Protective and pathogenic antibody responses at barrier organsis a collaborative doctoral programme jointly organized by theUniversity of LübeckandKiel University two modern and research-intensive universities with strong profiles in medicine molecular biology and life sciences. Their study programmes have consistently achievedtop rankings in the CHE Ranking the most comprehensive evaluation of study programmes at German universities.
Immunological barrier organs such as theskin intestine and lungsare continuously exposed to commensal microorganisms pathogens and environmental allergens. As a result infections as well as allergic and autoinflammatory disorders at these mucosal interfaces are frequent and represent asignificant burden to public health. Antibody-mediated immune responses play acentral rolein maintaining homeostasis at these sites: they contribute to thecontrol of pathogen invasion theregulation of gut microbiota and theinitiation and modulation of allergic reactions while also exerting regulatory functions that candownregulate inflammation.
The overarching goal of RTG 3095 is to elucidate themechanisms by which B cell responses are initiated maintained and contribute to either immunoprotection or immunopathogenesisat these immunological barrier sites. To achieve this the programme employsstate-of-the-art experimental approaches includingsingle-cell sequencingspatial transcriptomics and advanced molecular and immunological techniques. Doctoral researchers will benefit from astructured 4-year training programmethat integrates cutting-edge research with comprehensive training opportunities.
Start in our team
Within this framework the subproject P07 Identification and comparative analysis of circulating and mucosal autoantibody producing B cells in GPAled byProf. Peter Lamprecht and Prof Antje Müllerat theDepartment of Rheumatology and Clinical Immunology University of Lübeck is seeking aPhD Candidate to start onApril 1 2026. The position is initially limited untilMarch 31 2030.
What we offer:
Your tasks:
Your profile:
Application:
Please submit your application until14th December 2025indicating the reference number27553.
Please include the following documents with your application:
Selection process
Application to this subproject of RTG 3095 is generally considered to be an application also to the other subprojects of RTG 3095. Separate application to another subproject is not required but please indicate in your motivation letter your favored RTG3095 subprojects (see above motivation letter).
Among the written applications the most suitable candidates will be invited to a one-day symposium which will take place in January 2026 in Lübeck Germany.
For further information please contact: Prof. Peter Lamprecht (E-Mail: ) or Prof. Antje Müller (E-Mail: Antje.Mü) Department of Rheumatology and Clinical Immunology University of Lübeck.